FDA panel narrowly recommends authorization of first antiviral pill to treat COVID – STAT See also: An FDA panel supports Merck COVID drug in mixed vote – NPR Related: [Press release – not published yet] Merck’s new Covid-19 pill Molnupiravir updated data shows reduced efficacy (30%) for preventing hospitalization and death compared to initial results […]

The post FDA panel narrowly recommends authorization of first antiviral pill to treat COVID. appeared first on Links Medicus.